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Abstract
Background: The sequence of the pathogen Mycobacterium tuberculosis (Mtb) strain H37Rv has been available for
over a decade, but the biology of the pathogen remains poorly understood. Genome sequences from other Mtb
strains and closely related bacteria present an opportunity to apply the power of comparative genomics to
understand the evolution of Mtb pathogenesis. We conducted a comparative analysis using 31 genomes from the
Tuberculosis Database (TBDB.org), including 8 strains of Mtb and M. bovis, 11 additional Mycobacteria, 4
Corynebacteria, 2 Streptomyces, Rhodococcus jostii RHA1, Nocardia farcinia, Acidothermus cellulolyticus, Rhodobacter
sphaeroides, Propionibacterium acnes, and Bifidobacterium longum.
Results: Our results highlight the functional importance of lipid metabolism and its regulation, and reveal variation
between the evolutionary profiles of genes implicated in saturated and unsaturated fatty acid metabolism. It also
suggests that DNA repair and molybdopterin cofactors are important in pathogenic Mycobacteria. By analyzing
sequence conservation and gene expression data, we identify nearly 400 conserved noncoding regions. These
include 37 predicted promoter regulatory motifs, of which 14 correspond to previously validated motifs, as well as
50 potential noncoding RNAs, of which we experimentally confirm the expression of four.
Conclusions: Our analysis of protein evolution highlights gene families that are associated with the adaptation of
environmental Mycobacteria to obligate pathogenesis. These families include fatty acid metabolism, DNA repair,
and molybdopterin biosynthesis. Our analysis reinforces recent findings suggesting that small noncoding RNAs are
more common in Mycobacteria than previously expected. Our data provide a foundation for understanding the
genome and biology of Mtb in a comparative context, and are available online and through TBDB.org.
Keywords: Comparative genomics, M. tuberculosis, SYNERGY, Small RNAs, Lipid metabolism, Molybdopterin, DNA
repair
Background
Tuberculosis is still a major killer worldwide, causing an
estimated 2-3 million deaths per year [1]. The sequence of
the pathogen Mycobacterium tuberculosis (Mtb)s t r a i n
H37Rv has been available for a decade [2,3], but the biol-
ogy of the pathogen remains poorly understood. Available
genome sequences from Mtb strains and other closely
related Mycobacteria present an opportunity to bring the
power of comparative genomics to the study of Mtb.
We report here the results of a comparative analysis of
31 publicly available genomes (http://www.tbdb.org,
Figure 1, Table 1). These include eight closely related
members of the Mtb complex that can cause tuberculosis
disease, (two M. bovis strains and six Mtb strains).
Another 11 additional Mycobacteria range from obligate
parasites to free-living soil bacteria: M. leprae and
M. avium subsp. Paratuberculosis K10, the causative
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pathogenic and require hosts to survive; M. ulcerans, M.
marinum, M. avium 104,a n dM. abscessus have the
potential to be pathogenic but can survive outside the
confines of a host; M. vanbaalenii, M. sp. KMS, M. sp.
MCS,a n dM. gilvum are free-living soil bacteria which
are known to degrade a variety of compounds including
polycyclic aromatic hydrocarbons (PAH), and are useful
in bioremediation efforts. Thus, the Mycobacteria
included in our dataset span an ecological range from
host-dependent pathogens to soil bacteria, allowing us to
study multiple evolutionary transitions.
Figure 1 Phylogenetic Tree based on uniform SYNERGY orthogroups, scaled by phylogenetic distance. The labels A-C indicate the branches
selected for further analysis in our dN/dS analysis (A: The branch leading to the Mtb cluster; B: The branch leading to the pathogenic Mycobacteria; C:
The branch leading to the non-pathogenic, soil-dwelling Mycobacteria). See Methods for details on the phylogenetic tree construction.
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Page 2 of 27To gain further insight into the Mycobacterium clus-
ter, we also included a related Rhodococcus (also
involved in bioremediation), a pathogenic Nocardia,
four Corynebacteria (two pathogens and two that are
commercially useful in amino acid production), two
Streptomyces (antibiotic-producing soil bacteria), Acid-
othermus cellulolyticus (a thermophilic actinobacteria
from the hot springs of Yellowstone), Propionibacterium
acnes (causative agent of common acne), and Bifidobac-
terium longum (a digestive track commensal often found
Table 1 Summary of Organisms
Organism Patho-
genic
Host
required
Description Reference
Mycobacterium tuberculosis
H37Rv
Y Y Causes TB; Laboratory strain [2]
Mycobacterium tuberculosis
H37Ra
Y Y Causes TB; Avirulent sister strain to H37Rv [4]
Mycobacterium tuberculosis F11
(ExPEC)
Y Y Causes TB; isolated from TB patient in S. Africa [5]
Mycobacterium bovis BCG str.
Pasteur 1173P2
Y Y Causes bovine TB; attenuated vaccine strain [6]
Mycobacterium bovis AF2122/97 Y Y Causes bovine TB [7]
Mycobacterium tuberculosis
Haarlem
Y Y Causes TB; MDR strain [5]
Mycobacterium tuberculosis C Y Y Causes TB; isolated in NY City [5]
Mycobacterium tuberculosis
CDC1551
Y Y Causes TB; highly contagious & virulent strain [8]
Mycobacterium ulcerans AGY99 Y Causes Buruli ulcer [9]
Mycobacterium marinum Y From fish; Skin lesions in human [10]
Mycobacterium leprae TN Y Y Causes leprosy [11]
Mycobacterium avium 104 Y Opportunistic pathogen; can causeTB-type pulmonary infection [12]
Mycobacterium avium subsp.
Paratuberculosis K-10
Y Y Causes paratuberculosis; obligate pathogen of cattle [13]
Mycobacterium sp. MCS Soil bacteria; degrades PAH [14]
Mycobacterium sp. KMS Soil bacteria; degrades PAH [14]
Mycobacterium smegmatis
MC2155
Y Widely used model for Mtb isolated from human smegma; causes soft tissue
lesions
[12]
Mycobacterium vanbaalenii PYR-1 Soil bacteria; degrades PAH [14]
Mycobacterium gilvum Soil bacteria; Degrades PAH + wide variety of organic compounds [14]
Mycobacterium abscessus Y Skin & soft tissue infections [15]
Rhodococcus jostii RHA1 Soil bacteria important for biofuels research and bioremediation; degrades PCB
+ wide variety of organic compounds
[16]
Nocardia farcinica IFM 10152 Y Causes nocardiosis [17]
Corynebacterium glutamicum
ATCC 13032
Produces amino acids (Glu) [18]
Corynebacterium efficiens YS-314 Produces amino acids (Glu) [19]
Corynebacterium diphtheriae
NCTC13129
Y Causes diphtheria [20]
Corynebacterium jeikeium K411 Y Causes nocosomial infections [21]
Streptomyces avermitilis MA-4680 Soil bacteria;antibiotic-producing [22]
Streptomyces coelicolor A3(2) Soil bacteria;antibiotic producing [23]
Acidothermus cellulolyticus 11B Hot springs of Yellowstone [24]
Rhodobacter sphaeroides Gram -, motile; photosyn.; fixes N2 [14]
Propionibacterium Acnes
KPA171202
Y Causes acne [25]
Bifidobacterium Longum NCC2705 Digestive track commensal; yogurt [26]
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Page 3 of 27in yogurt). We extend this comparative analysis to other
more distantly related Actinobacteria to yield additional
insight into evolutionary trends.
We examined protein evolution across these 31 organ-
isms, both at the nucleotide level and at the level of pro-
tein families, including studying gene families associated
with the transition from nonpathogenic soil-dwelling
bacteria to obligate pathogens. Our results highlight the
importance of lipid metabolism and its regulation, and
reveal differences in the evolutionary profiles for genes
implicated in saturated and unsaturated fatty acid meta-
bolism. Our analysis also suggests that DNA repair and
molybdopterin cofactors are expanded in pathogenic
Mycobacteria and Mtb.
We also identified highly conserved elements within
noncoding regions using whole-genome multiple align-
ments and gene expression data. These conserved ele-
ments include 37 predicted conserved promoter
regulatory motifs, of which 14 correspond to previously
reported motifs. They also include approximately 50 pre-
dicted novel noncoding RNAs. Guided by our computa-
tional analysis, we tested and experimentally confirmed
the expression of 4 novel small RNAs in Mtb.
The results of our analyses are available on our web-
site, and provide a foundation for understanding the
genome and biology of Mtb in a comparative context.
Results and discussion
An orthogroup catalogue for Mycobacteria
We used SYNERGY [27,28] to reconstruct the phylogeny
of proteins across all 31 organisms, define sets of ortho-
logs (“orthogroups”), and construct a phylogenetic tree of
the genomes (Figure 1). An orthogroup is defined as the
set of genes descended from a single common ancestral
gene in the last common ancestor of the species under
consideration [28], containing both orthologs and possi-
bly paralogs (Methods). At each node in the phylogenetic
tree, we tabulated orthogroup appearances, duplications,
a n dl o s s e s( F i g u r e2 ) .F i g u r e2g i v e sa no v e r v i e wo ft h e
evolution of gene families within these species. Full list-
ings of the events tabulated in Figure 2, as well as addi-
tional information about each orthogroup, can be found
on the Supplementary Information website:
Tracing the evolution of biological processes
To examine the evolution of entire pathways and gene
families, we categorized orthogroups according to GO
(Gene Ontology) and GO Slim terms [29], PFAM
domains [30], metabolic pathways, predicted regulons
(sets of genes predicted to be regulated by a common
regulatory protein), and groups of genes upregulated
under certain lipids (Methods). We also looked for
orthogroups undergoing positive selection by calculating
the ratio of nonsynonymous to synonymous mutations
(the dN/dS ratio). Figure 3 shows several examples of
pathway or gene family profiles and the predicted evolu-
tionary events associated with the gene family. The sort
of graphic presented in Figure 3 is browsable for every
pathway, PFAM, and GO term in our Supplementary
Information website. Tables 2 and 3 show the PFAM and
GO categories most expanded (with the most orthogroup
members) in the Mtb clade relative to the non-patho-
genic Mycobacteria, and Tables 4 and 5 show those most
expanded in the Mycobacteria relative to the non-
Mycobacteria.
Substantial expansion of known pathogenicity and lipid
metabolism genes
Despite the smaller genome sizes present in the patho-
genic Mycobacteria, and the resulting background of
orthogroup loss in the evolution towards pathogens, we
observe significant expansions in certain gene families in
the pathogenic Mycobacteria and the Mtb complex rela-
tive to non-pathogenic relatives. We also observe evidence
for selection in certain families on branches leading to the
pathogenic Mycobacteria, the Mtb complex, and the soil-
dwelling Mycobacteria.
As expected, many genes known to be related to patho-
genicity or antigenic variability are among the groups
most expanded in the Mtb clade relative to soil dwelling
Mycobacteria as well as being among the categories with
the most variability in copy number in their category-level
profiles overall, including toxin-antitoxin genes, genes
containing PE (Pro-Glu) and PPE (Pro-Pro-Glu) domains,
MCE (Mammalian Cell Entry) genes, genes involved in
the synthesis of the mycolic acid coat, Esx genes, and gene
involved in antibiotic resistance. Complete results for all
groupings are available on our Supplementary Informa-
tion website. Below we focus on specific additional
families showing noteworthy expansions and trends.
The single most significant trend in our analysis of pro-
tein family evolution is that genes related to lipid metabo-
lism are greatly expanded across all Mycobacteria and
related organisms, consistent with previous observations
[2,31] (Table 5). Our analysis extends these previous
observations by identifying the emergence of this expan-
sion in lipid metabolism genes as occurring at the root
node of the Mycobacteria and Rhodococcus (Figure 3).
Particular expansion of saturated fatty acid metabolism
and lipid synthesis genes in pathogenic Mycobacteria
Genes predicted to be involved in the metabolism of satu-
rated fatty acids are more expanded than those involved in
the metabolism of unsaturated fatty acids. Using a com-
pendium of microarray expression experiments (Meth-
ods), we compiled a list of genes upregulated in the
presence of different fatty acid sources. We found that
genes upregulated under unsaturated conditions have
McGuire et al. BMC Genomics 2012, 13:120
http://www.biomedcentral.com/1471-2164/13/120
Page 4 of 27more uniform phylogenetic profiles, while those upregu-
lated under saturated conditions, cholesterol or ceramide
have expanded through duplications in pathogenic Myco-
bacteria (Figure 4). Saturated fatty acids and cholesterol
are more prevalent in an animal host than in the soil,
which contains mostly unsaturated fatty acid from plant
inputs. Since it is believed that Mtb uses cholesterol as a
carbon source within the host [32], this could reflect an
Figure 2 Summary of SYNERGY results: Number of gains, losses, and duplication at each node. For each node, the node number is
marked in black; the total number of genes present at each node is indicated in red, and the numbers of gains, losses, and duplications are
indicated in parenthesis in blue http://www.broadinstitute.org/ftp/pub/seq/msc/pub/SYNERGY/index.html.
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Page 5 of 27adaptation to the host environment. Consistent with our
observations in host-adapted Mycobacteria, Desulfovibrio
desulfuricans intestinal strains contain a higher ratio of
saturated to unsaturated fatty acids than soil strains of
Desulfovibrio desulfuricans [33].
Our analysis also reveals differences in evolutionary
profiles between genes predicted to be involved in cata-
bolism and anabolism of lipids. Both sets of genes are
expanded in soil-dwelling and pathogenic Mycobacteria,
but lipid synthesis genes are additionally expanded in
pathogens relative to soil dwellers. General lipid synth-
esis genes are expanded across the Mycobacteria, but
certain groups of lipid synthesis genes, including those
related to cell wall synthesis, are further expanded in
the Mtb complex (see Supplementary Information). In
pathogenic Mycobacteria, the waxy mycolic acid coat
helps evade the host immune system [34]. Consistent
with this, we see categories related to mycolic acid
synthesis showing up among the most non-uniform
categories, highly expanded in the Mtb complex (see
Supplementary Information).
In contrast, some lipid degradation gene families are
more expanded in the soil-dwelling Mycobacteria than
in the pathogens (Supplementary Data). The soil-dwell-
ers have the unusual ability to degrade a vast array of
compounds, including diverse lipids.
Positive selection of lipid metabolism genes
In addition to gene family expansions, we observe evi-
dence for selection on the coding sequence of lipid meta-
bolism genes. In our dN/dS calculations, we observe
enrichment for positive selection in lipid degradation
genes on the branch leading to the pathogenic Mycobac-
teria (Additional file 1: Table S2). For example, Rv2524c,
the multifunctional FAS-I polypeptide utilized during de
novo fatty synthesis [35], has the second highest dN/dS
value on this branch. Additional lipid metabolism genes
with elevated dN/dS values include 15 genes predicted to
be involved in the b-oxidation pathway of fatty acid
degradation: seven fadE (acyl coA dehydrogenase) genes,
three fadD (fatty acid CoA ligase) genes, two fadB
(NADPH quinone oxidoreductase/3-hydroxybutyryl-CoA
dehydrogenase) genes, one fadA (acetyl-CoA acyltrans-
ferase) gene, and two echA (enoyl-CoA hydratase) genes.
Hence, we observe expansions of lipid biosynthesis genes,
as well as observing evidence for positive selection acting
on genes within the b-oxidation pathway. Both the lipid
biosynthesis and lipid degradation pathways are specia-
lized within the pathogenic Mycobacteria. This expansion
could possibly benefit the pathogen in a manner to
accommodate production and modification of cell wall
lipids involved in manipulation of host immune response.
The lipid degradation is particularly beneficial for the
Figure 3 Evolution of gene categories. This figure shows several examples of the evolution of metabolic pathways, PFAM domains, and GO
term descriptors. Graphics similar to these can be found for each category in the supplementary information website at http://www.
broadinstitute.org/ftp/pub/seq/msc/pub/SYNERGY/index.html. a) Fatty acid degradation metabolic pathway. b) PFAM group PF00823 (PPE genes).
c) PFAM group PF00440 (tetR family transcription factors). d) GO term 0009405 (pathogenesis.)
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Page 6 of 27Table 2 50 PFAM categories most expanded in the Mtb clade relative to the non-pathogenic, soil-dwelling
Mycobacteria
PFAM name PFAM ID p-value
a inter-to-intra-
centroid difference
b PIN domain PF01850 4.20E-09 1.10E+01
GHMP kinases C terminal PF08544 1.00E-08 8.80E+00
DHHA1 domain PF02272 2.10E-08 6.80E+00
KGG Stress-induced bacterial acidophilic repeat motif PF10685 6.70E-08 6.20E+00
b Protein of unknown function (DUF1396) (lipoproteins within cell wall) PF07161 4.10E-07 9.20E+00
b Rv0623-like transcription factor (toxin-antitoxin-related) PF07704 9.30E-07 1.00E+01
Tetratricopeptide repeat PF07720 9.90E-07 8.60E+00
PA domain PF02225 1.00E-06 6.40E+00
c Patatin-like phospholipase PF01734 1.20E-06 9.20E+00
e Protein of unknown function (DUF1490) PF07371 1.20E-06 1.00E+01
4 FAD binding domain PF01565 1.30E-06 6.40E+00
Fumarate reductase/succinate dehydrog. flavoprotein C-term domain PF02910 1.50E-06 5.90E+00
FIST C domain PF10442 2.00E-06 1.20E+01
Corticotropin ACTH domain PF00976 2.30E-06 6.00E+00
c Beta-ketoacyl synthase, N-terminal domain PF00109 2.40E-06 5.00E+00
IlvB leader peptide PF08049 4.20E-06 3.50E+00
c Beta-ketoacyl synthase, C-terminal domain PF02801 4.50E-06 4.80E+00
c Acyl transferase domain PF00698 4.60E-06 5.20E+00
b PPE family (antigenic variability) PF00823 5.60E-06 1.00E+01
b Proteins of 100 residues with WXG (esx-related) PF06013 7.10E-06 7.90E+00
b Phd YefM (toxin-antitoxin-related) PF02604 7.70E-06 9.00E+00
Ponericin PF07442 7.70E-06 8.70E+00
b Plasmid stabilization system protein (toxin-antitoxin-related) PF05016 9.90E-06 9.30E+00
Threonine leader peptide PF08254 1.10E-05 8.90E+00
Toxin 33 Waglerin family PF08121 2.20E-05 3.20E+00
Phosphatidylethanolamine-binding protein PF01161 2.20E-05 7.30E+00
b PemK-like protein (toxin-antitoxin-related) PF02452 3.10E-05 9.00E+00
Erythronolide synthase docking PF08990 5.60E-05 7.30E+00
d Radical SAM superfamily PF04055 5.80E-05 3.90E+00
d ThiS family PF02597 6.60E-05 5.60E+00
b Pentapeptide repeats (8 copies) PF01469 1.20E-04 1.00E+01
Rubredoxin PF00301 1.30E-04 3.80E+00
d Pterin 4 alpha carbinolamine dehydratase PF01329 1.50E-04 8.80E+00
Leucine rich repeat N-terminal domain PF01462 1.60E-04 1.00E+01
e Domain of unknown function (DUF1610) PF07754 2.10E-04 2.40E+00
SEC-C motif PF02810 2.30E-04 3.00E+00
d MoaC family PF01967 2.60E-04 7.10E+00
Berberine and berberine like PF08031 2.70E-04 9.30E+00
Cytochrome B6-F complex subunit VI (PetL) PF05115 2.80E-04 9.40E+00
Region found in RelA/SpoT proteins PF04607 3.00E-04 5.00E+00
Quinolinate phosphoribosyl transferase, C-terminal domain PF01729 3.30E-04 4.20E+00
Fumarate reductase subunit C PF02300 3.70E-04 1.00E+01
LHC Antenna complex alpha/beta subunit PF00556 5.00E-04 3.20E+00
RNPHF zinc finger PF08080 5.10E-04 6.50E+00
Protein of unknown function (DUF1416) PF07210 5.20E-04 9.60E+00
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Page 7 of 27Table 2 50 PFAM categories most expanded in the Mtb clade relative to the non-pathogenic, soil-dwelling Mycobac-
teria (Continued)
PsbJ PF01788 5.40E-04 3.70E+00
Bacterial transferase hexapeptide (three repeats) PF00132 5.50E-04 3.00E+00
N Chalcone and stilbene synthases, N-terminal domain PF00195 6.60E-04 8.40E+00
d MoaE protein PF02391 8.00E-04 7.80E+00
b Protein of unknown function (DUF1066) (esx) PF06359 8.30E-04 1.10E+01
a Bonferroni-corrected p-value calculated from T-test
b pathogenicity or survival within the host
c Lipid metabolism
d Pterin cofactor biosynthesis
e unknown function
Table 3 The 50 GO terms most expanded in the Mtb clade relative to the non-pathogenic, soil-dwelling Mycobacteria
GO descriptor GO term ID p-value
a inter-to-intra centroid difference
4-hydroxy-3-methylbut-2-en-1-yl diphosphate red. activity GO_0051745 4.80E-08 7.20E+00
dTMP biosynthetic process GO_0006231 7.30E-07 4.40E+00
response to cAMP GO_0051591 1.40E-06 1.20E+01
succinate dehydrogenase (ubiquinone) activity GO_0008177 1.70E-06 5.10E+00
iron ion transport GO_0006826 2.70E-06 4.70E+00
magnesium ion binding GO_0000287 2.80E-06 1.70E+00
c fatty-acyl-CoA synthase activity GO_0004321 5.10E-06 6.50E+00
c acyltransferase activity GO_0008415 7.60E-06 3.60E+00
transferase activity, transferring alkyl or aryl (other than methyl) groups GO_0016765 1.30E-05 2.60E+00
c tricarboxylic acid cycle GO_0006099 1.30E-05 3.40E+00
d Mo-molybdopterin cofactor biosynthetic process GO_0006777 1.40E-05 6.30E+00
integral to membrane GO_0016021 2.00E-05 2.00E+00
acid phosphatase activity GO_0003993 2.50E-05 3.20E+00
phosphatase activity GO_0016791 3.20E-05 4.10E+00
erythronolide synthase activity GO_0047879 4.20E-05 8.20E+00
d 4-alpha-hydroxytetrahydrobiopterin dehydratase activity GO_0008124 6.80E-05 6.20E+00
c lipid metabolic process GO_0006629 6.80E-05 4.70E+00
bacteriochlorophyll biosynthetic process GO_0030494 7.00E-05 1.30E+00
plasma membrane GO_0005886 7.10E-05 2.70E+00
d tetrahydrobiopterin biosynthetic process GO_0006729 1.10E-04 8.80E+00
c lipid biosynthetic process GO_0008610 1.20E-04 3.50E+00
phosphatidylcholine metabolic process GO_0046470 1.60E-04 9.50E+00
c geranyltranstransferase activity GO_0004337 1.60E-04 6.80E+00
cytoplasm GO_0005737 1.90E-04 1.40E+00
protein transport GO_0015031 1.90E-04 1.70E+00
guanosine tetraphosphate metabolic process GO_0015969 2.20E-04 5.00E+00
glyoxylate cycle GO_0006097 2.20E-04 4.30E+00
phosphoglycolate phosphatase activity GO_0008967 2.80E-04 4.30E+00
terpenoid biosynthetic process GO_0016114 3.90E-04 2.80E+00
sulfur metabolic process GO_0006790 4.10E-04 5.30E+00
4 iron, 4 sulfur cluster binding GO_0051539 5.00E-04 2.90E+00
succinate dehydrogenase activity GO_0000104 5.70E-04 4.60E+00
b mycocerosate synthase activity GO_0050111 5.80E-04 4.10E+00
c phospholipid biosynthetic process GO_0008654 6.10E-04 2.30E+00
nucleoside metabolic process GO_0009116 6.30E-04 3.60E+00
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Page 8 of 27Table 3 The 50 GO terms most expanded in the Mtb clade relative to the non-pathogenic, soil-dwelling Mycobacteria
(Continued)
c phosphopantetheine binding GO_0031177 8.20E-04 3.00E+00
adenylate cyclase activity GO_0004016 8.30E-04 5.50E+00
D-arabinono-1,4-lactone oxidase activity GO_0003885 9.70E-04 8.40E+00
anaerobic respiration GO_0009061 9.90E-04 1.10E+01
nodulation GO_0009877 1.10E-03 7.10E+00
c prenyltransferase activity GO_0004659 1.10E-03 4.20E+00
c lysophospholipase activity GO_0004622 1.30E-03 8.50E+00
c acetyl-CoA carboxylase activity GO_0003989 1.30E-03 2.40E+00
histidinol-phosphatase activity GO_0004401 2.10E-03 6.50E+00
pyridine nucleotide biosynthetic process GO_0019363 2.30E-03 5.00E+00
NAD biosynthetic process GO_0009435 3.30E-03 1.30E+00
lactate fermentation to propionate and acetate GO_0019652 3.40E-03 3.40E+00
alkylglycerone-phosphate synthase activity GO_0008609 3.40E-03 7.10E+00
b cyclopropane-fatty-acyl-phospholipid synthase activity GO_0008825 4.00E-03 5.90E+00
methylcrotonoyl-CoA carboxylase activity GO_0004485 4.40E-03 3.00E+00
aBonferroni-corrected p-value calculated from T-test
b pathogenicity or survival within the host
c Lipid metabolism
d Cofactor biosynthesis
e unknown function
Table 4 The 50 PFAM categories most expanded in the Mycobacteria relative to the non- Mycobacteria
PFAM descriptor PFAM ID p-value
a inter-to-intra centroid difference
e Protein of unknown function (DUF2599) PF10783 1.50E-10 8.80E+00
c Cutinase PF01083 1.60E-10 1.50E+01
e Uncharacterized protein conserved in bacteria (DUF2236) PF09995 2.20E-10 1.60E+01
c Lpp-LpqN Probable lipoprotein LpqN PF10738 4.70E-10 1.30E+01
e Domain of unknown function (DUF385) PF04075 5.70E-10 1.30E+01
b Domain of unk function DUF140 (yrbE genes in mce operons) PF02405 1.60E-09 1.40E+01
Retinal pigment epithelial membrane protein PF03055 8.50E-09 1.40E+01
e Domain of unknown function (DUF427) PF04248 1.40E-08 1.60E+01
ABC transporter transmembrane region 2 PF06472 PF06472 1.80E-08 1.10E+01
b Peroxidase (katG-isoniazid resistance) PF00141 4.10E-08 1.20E+01
b mce related protein PF02470 1.30E-07 1.30E+01
N O-methyltransferase N-terminus PF02409 1.70E-07 1.70E+01
Activator of Hsp90 ATPase homolog 1-like protein PF08327 2.40E-07 1.10E+01
Coronavirus nonstructural protein NS1 PF06145 3.00E-07 1.20E+01
e Predicted integral membrane protein (DUF2189) PF09955 3.10E-07 1.40E+01
e Uncharacterized protein family (UPF0089) PF03007 3.80E-07 1.50E+01
b Acetyltransf 2 N-acetyltransferase (inactivates isoniazid) PF00797 3.90E-07 1.70E+01
e Domain of unknown function (DUF1957) PF09210 5.50E-07 7.90E+00
KRAB box PF01352 7.00E-07 1.70E+01
Prokaryotic acetaldehyde dehydrogenase, dimerisation PF09290 8.10E-07 9.00E+00
DmpG-like communication domain PF07836 9.50E-07 1.10E+01
Nuclear transport factor 2 (NTF2) domain PF02136 1.00E-06 1.30E+01
Wyosine base formation PF08608 1.10E-06 1.40E+01
AIG2-like family PF06094 1.30E-06 1.80E+01
e Protein of unknown function (DUF867) PF05908 1.30E-06 1.50E+01
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Page 9 of 27Table 4 The 50 PFAM categories most expanded in the Mycobacteria relative to the non- Mycobacteria (Continued)
Phage-related minor tail protein PF10145 2.10E-06 1.20E+01
c Fatty acid desaturase PF03405 2.30E-06 1.00E+01
PaaX-like protein PF07848 2.80E-06 1.50E+01
Adenylate and Guanylate cyclase catalytic domain PF00211 3.70E-06 1.10E+01
Fibronectin-attachment protein (FAP) PF07174 3.80E-06 1.30E+01
Leucine Rich Repeat PF07723 5.50E-06 1.10E+01
2-nitropropane dioxygenase PF03060 5.70E-06 1.40E+01
c Fatty acid desaturase PF00487 7.90E-06 1.30E+01
e Protein of unknown function (DUF732) PF05305 9.10E-06 1.50E+01
c Enoyl-CoA hydratase/isomerase family PF00378 9.70E-06 1.10E+01
arg-2/CPA1 leader peptide PF08252 1.00E-05 1.40E+01
c alpha/beta hydrolase fold (lipases) PF07859 1.10E-05 1.50E+01
Cytochrome P450 PF00067 1.40E-05 1.20E+01
c Cyclopropane-fatty-acyl-phospholipid synthase PF02353 PF02353 1.60E-05 1.20E+01
Isoprenylcysteine carboxyl methyltransferase (ICMT) family PF04140 1.90E-05 1.50E+01
Hydratase/decarboxylase PF01689 2.50E-05 6.60E+00
PsbJ PF01788 3.00E-05 9.40E+00
Linocin M18 bacteriocin protein PF04454 3.40E-05 1.60E+01
Extensin-like protein repeat PF02095 4.00E-05 1.50E+01
5HT transporter Serotonin (5-HT) neurotransmitter transporter, N-terminus PF03491 4.00E-05 9.50E+00
e Protein of unknown function (DUF571) PF04600 4.20E-05 7.70E+00
Tryptophyllin-3 skin active peptide PF08248 4.90E-05 1.50E+01
AMP-binding enzyme PF00501 8.10E-05 9.20E+00
e Bacterial protein of unknown function (DUF853) PF05872 9.90E-05 1.30E+01
c Acyl-ACP thioesterase PF01643 1.10E-04 1.10E+01
aBonferroni-corrected p-value calculated from T-test
b pathogenicity or survival within the host
c Lipid metabolism
d Cofactor biosynthesis
e unknown function
Table 5 The 50 GO terms most expanded in the Mycobacteria relative to the non- Mycobacteria
GO term descriptor GO term
ID
p-
value
a
inter-to-intra-centroid
difference
c sterol biosynthetic process GO:0016126 1.00E-10 1.80E+01
b regulation of apoptosis GO:0042981 1.10E-10 1.90E+01
c 3alpha,7alpha,12alpha-trihydroxy-5beta- cholest-24-enoyl-CoA hydratase activity GO:0033989 1.40E-10 1.70E+01
c linalool 8-monooxygenase activity GO:0050056 1.50E-10 1.70E+01
c sterol 14-demethylase activity GO:0008398 5.10E-09 1.60E+01
c cutinase activity GO:0050525 5.80E-09 1.60E+01
oxidoreductase activity, acting on NADH or NADPH, nitrogenous group as acceptor GO:0016657 1.80E-08 1.40E+01
c diacylglycerol O-acyltransferase activity GO:0004144 2.10E-08 1.70E+01
ligase activity, forming carbon-carbon bonds GO:0016885 6.10E-08 1.40E+01
indolylacetylinositol arabinosyltransferase activity GO:0050409 7.90E-08 1.20E+01
c 4-hydroxy-2-oxovalerate aldolase activity GO:0008701 1.00E-07 1.10E+01
arylamine N-acetyltransferase activity GO:0004060 2.80E-07 1.70E+01
c lipid transport GO:0006869 5.00E-07 1.70E+01
c lipid biosynthetic process GO:0008610 5.00E-07 8.50E+00
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Page 10 of 27long term survival of the pathogen metabolizing host
lipids encountered during infection.
Coordinated evolution of lipid metabolism genes and the
regulator KstR
KstR is a transcription factor known to be involved in
lipid and cholesterol degradation [36,37]. It has been
recently shown that Mtb uses cholesterol as a carbon
source within the host [32]. Strikingly, KstR exhibits an
evolutionary history that parallels the expansion of lipid
metabolism genes in the Mycobacteria, and displays a
singular conservation in its regulatory binding sites.
KstR appears to have evolved at the last common
ancestor of the Mycobacteria and Rhodococcus. In all
Table 5 The 50 GO terms most expanded in the Mycobacteria relative to the non- Mycobacteria (Continued)
biphenyl-2,3-diol 1,2-dioxygenase activity GO:0018583 1.40E-06 9.50E+00
cis-stilbene-oxide hydrolase activity GO:0033961 1.50E-06 1.20E+01
c acyl-[acyl-carrier-protein] desaturase activity GO:0045300 1.70E-06 1.00E+01
5-carboxymethyl-2-hydroxymuconic-semialdehyde dehydrog activity GO:0018480 2.00E-06 1.20E+01
c fatty-acyl-CoA synthase activity GO:0004321 2.10E-06 1.20E+01
c steroid biosynthetic process GO:0006694 2.30E-06 1.20E+01
c propanoyl-CoA C-acyltransferase activity GO:0033814 2.50E-06 1.20E+01
extracellular matrix binding GO:0050840 2.70E-06 1.30E+01
lipid glycosylation GO:0030259 6.70E-06 5.60E+00
d coenzyme F420-dependent N5, N10-methenyltetrahydromethanopterinreductase
activity
GO:0018537 6.90E-06 1.20E+01
C-terminal protein amino acid methylation GO:0006481 1.10E-05 1.10E+01
metabolic process GO:0008152 1.30E-05 4.60E+00
4-oxalocrotonate decarboxylase activity GO:0047437 1.70E-05 1.10E+01
oxidoreductase activity GO:0016491 1.80E-05 5.20E+00
oxidation reduction GO:0055114 1.90E-05 4.80E+00
defense response to bacterium GO:0042742 2.40E-05 1.60E+01
b cyclopropane-fatty-acyl-phospholipid synthase activity GO:0008825 2.90E-05 9.80E+00
c 3-hydroxy-2-methylbutyryl-CoA dehyd. activity GO:0047015 3.40E-05 1.10E+01
nutrient reservoir activity GO:0045735 3.40E-05 9.30E+00
structural constituent of cell wall GO:0005199 3.60E-05 7.90E+00
2-nitropropane dioxygenase activity GO:0018580 4.10E-05 1.40E+01
adenylate cyclase activity GO:0004016 6.00E-05 9.50E+00
b beta-lactam antibiotic catabolic process GO:0030655 6.70E-05 1.40E+01
DNA primase activity GO:0003896 8.40E-05 1.10E+01
cyclic nucleotide biosynthetic process GO:0009190 8.50E-05 9.80E+00
iron ion transport GO:0006826 8.70E-05 1.20E+01
di-, tri-valent inorganic cation transmembrane transporter activity GO:0015082 9.00E-05 6.80E+00
phosphorus-oxygen lyase activity GO:0016849 1.60E-04 9.50E+00
limonene-1,2-epoxide hydrolase activity GO:0018744 1.60E-04 7.80E+00
c fatty acid metabolic process GO:0006631 1.70E-04 8.40E+00
sirohydrochlorin cobaltochelatase activity GO:0016852 1.80E-04 1.50E+01
intracellular signaling cascade GO:0007242 2.00E-04 8.80E+00
c enoyl-CoA hydratase activity GO:0004300 2.30E-04 1.30E+01
di-, tri-valent inorganic cation transport GO:0015674 2.40E-04 6.20E+00
c acyl-CoA dehydrogenase activity GO:0003995 2.60E-04 9.10E+00
catechol O-methyltransferase activity GO:0016206 3.20E-04 1.50E+01
aBonferroni-corrected p-value calculated from T-test
b pathogenicity or survival within the host
c Lipid metabolism
d Cofactor biosynthesis
e unknown function
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Page 11 of 27Mycobacteria analyzed (except M. leprae), Rhodococcus,
and Nocardia there is one highly conserved ortholog of
the KstR gene. However, in organisms more distantly
related to Mtb,t h eKstR gene is not present in a single
copy. Rather, 2-3 paralogs of KstR are present in these
more distantly related organisms, as well as the environ-
mental Mycobacteria, including M. ulcerans, M. avium
1 0 4 ,M .s p .M C S ,M .s p .K M S ,a n dM. vanbaalenii
(Additional file 2: Figure S1). Remarkably, these paralogs
of KstR are all absent in the pathogenic Mycobacteria.
Thus, coincident with the expansion in lipid metabolism
genes described above, the KstR gene appears to have
emerged through gene duplication within the existing
gene family of tetR-like transcriptional regulators at the
last common ancestor of Mycobacteria and Rhodococcus.
All other members of this gene family were subse-
quently lost in the Mtb complex, while the KstR protein
was maintained and underwent limited sequence
divergence.
There is another homolog to KstR found in Mtb H37Rv
(Rv3557c) that has previously been reported to also be
involved in cholesterol metabolism, named KstR2 [38].
However, KstR is much more similar to the other mem-
bers of the Mycobacterial tetR family discussed above
than it is to KstR2. KstR2 is categorized into a separate
orthogroup (orthogroup 32655) and is more distantly
related to KstR.
The high sequence conservation of the KstR transcrip-
tion factor is mirrored in the conservation of KstR binding
sites across numerous promoters. KstR binding sites are
known to be highly conserved across the Mycobacteria,
out to Rhodococcus and Nocardia [36]. These sites are
conserved in both sequence and position within their
respective promoters. In our analysis, both in searches
using known transcription factor binding motifs, as well as
in our de novo motif searches, a subset of KstR binding
sites are the most conserved transcription factor motifs
observed. They are also among the most conserved of any
noncoding sequence we identified. The conservation of
the KstR gene and binding sites, the emergence of KstR at
the ancestor of Rhodococcus and the Mycobacteria, and
the loss of KstR paralogs within the pathogenic Mycobac-
teria, suggests that this transcription factor and its evolving
regulon have played an important role in the expansion of
lipid metabolism and its adaptation to pathogenicity in
Mtb.
Positive selection of DNA repair genes
Mtb, as well as non-tuberculous Mycobacteria, differ
from other bacteria in several key respects of DNA repair
Figure 4 Evolution of genes upregulated when grown on saturated or unsaturated fatty acids. Genes upregulated by at least 1.5
standard deviations are indicated here. a) Genes expressed under palmitic acid but not oleic or linoleic (genes expressed in saturated fatty acid
conditions). b) Genes expressed under linoleic or oleic acid but not palmitic (genes expressed under unsaturated fatty acid conditions). c) The
ratio of the phylogenetic profiles for genes expressed under palmitic and linoleic acid, normalized by genome size.
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Page 12 of 27[39-42]. Within the host, Mtb must combat damage to its
DNA from macrophage-generated reactive oxygen and
nitrogen intermediates. The mechanisms by which this is
accomplished are not fully understood [43,44]. Although
genes implicated in DNA repair have not expanded in
the Mtb lineage, we note that the set of genes showing
positive selection on the Mtb lineage in our dN/dS analy-
sis is enriched for genes involved in the COG category
for DNA replication, recombination, and repair (Addi-
tional file 1: Table S2). Several of the genes in this set
with highest dN/dS values are known DNA repair genes
(including recA, recB,a n ddnaE2), and several additional
genes are helicases (dnaB, helZ, and gyrB).
Interestingly, we observe that recA has the highest dN/
dS score of all the genes in Mtb on the branch leading to
the Mtb complex, and recB also has a very high score.
Mycobacteria lack a mutSL-based mismatch repair
(MMR) system [42], and it is believed that recA may be
involved in compensating pathways. dnaE2 (DNA poly-
merase III) also has one of the highest dN/dS values on
the branch leading to Mtb, and both dnaE1 (DNA poly-
merase III) and dnaE2 show evidence of selection on the
branch leading to the pathogenic Mycobacteria. In Mtb,
damage-induced base-substitution mutagenesis is depen-
dent on dnaE2.L o s so fdnaE2 activity renders Mtb
hypersensitive to DNA damage, eliminates induced
mutagenesis, attenuates virulence, and reduces the fre-
quency of drug resistance in vivo [39,45]. dnaE1 provides
essential, high-fidelity replicative polymerase function
[39], and is expressed in response to DNA damage, along
with dnaE2 and recA [39,45].
We also observe positive selection for dinX (DNA poly-
merase IV) on the branch leading to the pathogenic Myco-
bacteria (branch-site model) in our dN/dS analysis (see
Supplementary Information website). Most organisms use
specialized DNA polymerases that are able to catalyze
translesion synthesis (TLS) across sites of damage, includ-
ing the dinB group of Y family polymerases. There are two
dinB-family polymerases in Mtb (dinX and dinP). Unlike
in other bacteria, dinX and dinP expression are not depen-
dent on recA, the SOS response, or the presence of DNA
damage, and could therefore serve a novel yet uncharac-
terized role in Mtb [46-49].
Expansion of pterin cofactors
Genes involved in the first steps of pterin cofactor (a com-
ponent of the molybdenum cofactor) biosynthesis are
known to be expanded in the Mtb complex [50]. Molybde-
num cofactor-requiring enzymes (such as xanthine oxidase
and aldehyde oxidase) could have physiological functions
in the metabolism of reactive oxygen species during stress
response [51]. Molybdenum cofactor is an efficient catalyst
in oxygen-transfer reactions, can be used in anaerobic
respiration, and can catalyze redox reactions in carbon,
nitrogen, and sulfur metabolism. Recently, genes related to
molybdenum cofactor protein synthesis have been shown
to be upregulated under conditions of stress in Mtb [52].
Molybdenum cofactor biosynthesis has been previously
linked to pathogenesis. The regulator of the moa1 locus,
MoaR1, was identified as having a SNP in M. bovis BCG,
but not in virulent M. bovis or Mtb [53]. In addition,
moa3 is present with varying frequency in the RD1 region,
which is absent in M. bovis BCG, of pathogenic strains
[54].
In agreement with previous observations of expansions
of molybdopterin biosynthesis genes, we observe five pro-
tein domains related to pterin cofactor biosynthesis
among the top protein domains expanded in the Mtb
complex compared to the non-pathogenic Mycobacteria
(Table 2, -"d”). Among the top GO terms expanded in the
Mtb clade relative to the soil dwellers (Table 3), there are
also several groups involved in pterin and molybdopterin
biosynthesis. Some of these gene copies (the moa1 locus)
are believed to have been acquired by lateral gene transfer
on the branch leading to the Mtb complex [10,50].
We also observe evidence for selection on molybdenum-
related genes in our dN/dS data. On the branch leading to
the pathogenic Mycobacteria, several orthogroups with
high log likelihood scores when testing for selection are
related to molybdenum (see Supplementary Information
website). The orthogroup containing BisC (biotin sulfoxide
reductase, a molybdoenzyme), as well as the orthogroup
containing ModA (an ABC-family molybdate transporter),
are among those with the highest dN/dS values on the
branch leading to the pathogens. MoaB2 is one of the
highest-scoring genes on all three branches tested.
Expansions of genes of unknown function in Mtb clade
There are also many categories of unknown function that
are greatly expanded in the Mtb clade relative to the non-
pathogenic Mycobacteria (Tables 2 and 3, red). For exam-
ple, Rv0918 (in the Pfam group of unknown function
PF08681) was found in a genetic screen that facilitates iso-
lation of mutants defective in arresting the maturation of
phagosomes [55], helping Mtb to survive within host cells.
PF07161 contains four lipoproteins (LprF, LprG, LprA,
LppX). LprG and LppX were found to be in vivo essential
genes by TraSH analysis [56].
Detection of conserved noncoding sequences
Sequence conservation - or phylogenetic footprinting -
provides a powerful approach for identifying potential
functional noncoding sequences, and has been used in a
variety of eukaryotic and prokaryotic organisms to identify
protein coding genes, noncoding RNAs, and regulatory
elements [57,58]. For optimal power, the organisms being
analyzed must be sufficiently distant such that non-func-
tional elements have diverged, but not so distant such that
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isms within the Mtb complex are all highly similar at the
sequence level, and thus by themselves do not allow for
effective phylogenetic footprinting. By leveraging the evo-
lutionary similarity of the most distantly related Mycobac-
teria and Actinomycetes, we gained additional power to
allow us to detect functional sequences under purifying
selection, albeit only those shared by at least a majority of
Mycobacteria. We used this approach to predict two
classes of conserved noncoding sequences: small noncod-
ing RNAs and transcription factor binding motifs.
Novel putative conserved small noncoding RNAs in
Mycobacteria
Small noncoding RNAs (sRNAs) have been shown to play
a role in regulating gene expression in numerous bacterial
species [59], including Streptococcus [60,61]. Yet only
recently were sRNAs reported in Mycobacteria [60,62].
Using a combination of direct isolation of small RNAs,
and validation by Northern blotting and 5’ and 3’ RACE
transcript mapping, Arnvig and Young [62] first described
nine sRNAs in Mtb. Subsequently, DiChiara et al. [63]
describe 34 small RNAs in M. bovis BCG, of which many
were conserved in both Mtb and M. smegmatis.
To build on these results, we used a combination of
comparative genomics, RNA-seq, and experimental valida-
tion by Northern blotting to identify additional sRNAs
conserved among the Mycobacteria (Methods). Our com-
putational results provide evidence for 50 conserved small
RNAs in Mtb that have not been previously reported. It is
likely that additional conserved regions are expressed
under other diverse conditions. Figure 5a shows the
expression and conservation map for one of our predicted
RNAs in the GenomeView Browser [64]. Table 6 shows a
listing of the top 12 candidate RNAs. To verify a subset of
these candidate small RNAs, we used Northern blot analy-
sis on four of the top predicted regions (Methods). The
results (Figure 5b) show signals corresponding to small
RNAs from each of four candidates (Table 6, labeled 1, 2,
3, and 9). All transcripts were near the expected size, or
slightly larger. Full-length gels are provided in Additional
file 3: Figure S2. Consistent with previous work, the major-
ity of small RNAs were seen as more than one size tran-
script [62]. This suggests that small RNAs might be
generated by processing of larger transcripts. In the RNA-
seq data, there are longer “tails” extending outside of the
main peak that corresponds to the RNA prediction–differ-
ent length RNAs could be responsible for the additional
bands of higher mass.
Conserved cis-regulatory motifs in Mycobacteria
Few transcription factor binding motifs have been identi-
fied in Mtb. Transcription factors for which binding motifs
have been identified include KstR [36], DosR [67], IdeR
[68], ZurB [69], Crp [70], CsoR [71], FurA [72], MprAB
[73], and Acr [74]. Because of the limited knowledge of
transcriptional regulation in Mtb, we searched for addi-
tional motifs computationally. We combined comparative
sequence analysis with microarray data to identify a large
number of motifs conserved in Mycobacteria.
We clustered microarray data contained in the TB
database [75] and searched for upstream regulatory
motifs shared in the upstream regions of the resulting
clusters using AlignACE (Methods). Because of signifi-
c a n tn o i s ei nt h er e s u l t s ,w eu s e das e to fs t r i n g e n tf i l -
ters, including a requirement that candidate motifs be
highly conserved. 37 motif instances passed our strin-
gent filters (Table 7, Methods). 14 of the top 37 (38%)
motif instances correspond to cases of known Mtb
motifs (several known Mtb motifs were found more
than once, in different clusters, or in clusters with differ-
ent size parameters). In contrast, none of the top motifs
showed similarity only to known E. coli or Corynebac-
teria motifs. Within these top motifs, we were able to
identify four of the nine known Mtb motifs (DosR, IdeR,
KstR, and ZurB).
As described above, the KstR motif shows a much
stronger signal, in terms of both conservation and infor-
mation content, than any of the other motifs (top of the
ranked conservation list, Table 7). Based on the distribu-
tion of highly conserved predicted motif instances for
KstR across the genome, we predict a more general role
for KstR in lipid metabolism. We see KstR motif
instances near many other lipid genes not related to
cholesterol degradation, in support of the view that
KstR is a more general lipid regulator controlling a large
regulon [36].
One of the most interesting new motif candidates that
shows up in our analysis is a conserved palindromic
motif, consisting of a highly conserved TAC... GTA
separated by 6 bp of less well conserved sequence
( m a r k e dw i t ha nXi nT a b l e7 )t h a ti sf o u n di nc l u s t e r s
of 2-3 closely spaced sites upstream of several genes
related to fatty acid metabolism (Figure 6). There is a
cluster of 3 evenly spaced sites upstream of Rv3229c
(linoeyl-coA desaturase), a cluster of 2 sites upstream of
the adjacent Rv3230c (oxidoreductase), and a cluster of
3 sites upstream of Rv2524c (fatty acid synthase). This is
the second highest-scoring new motif identified (Table
7). This motif shows up as one of the top motifs asso-
ciated with the clusters of genes upregulated under satu-
rated fatty acid conditions (specifically palmitate).
Conclusion
To better understand Mtb, we performed a comparative
analysis of 31 organisms from the Tuberculosis Data-
base. We studied the evolution of protein families and
metabolic pathways, looked for proteins with evidence
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Page 14 of 27Figure 5 New predicted RNAs. a) An example of a new predicted RNA. This is the RNA2 in Table 6. This figure shows a screenshot from the
GenomeView Browser [64]. The light blue bars show the coding regions (Rv1230c and Rv1231); the tan bar shows the conserved region
predicted by Gumby [65]; and the green bar shows the region predicted to fold by Evofold [66]. The yellow and green plots in the center show
the RNA-seq data. Green signifies reads from the negative strand, and yellow shows the total reads (positive and negative strands). The multiple
alignment is shown on the bottom (darker grey signifies a higher degree of conservation; red signifies no alignment at that position). You can
see that this predicted RNA region is conserved through M. avium. The rulers at the top show the gene structure. Small red squares show where
stop codons are present all six reading frames, indicating that this intergenic region is unlikely to be a protein-coding region missed in the
annotation. b) Northern blots validating four of the new, predicted small RNAs (RNA1, RNA2, RNA3, and RNA9 in Table 6).
McGuire et al. BMC Genomics 2012, 13:120
http://www.biomedcentral.com/1471-2164/13/120
Page 15 of 27Table 6 Top 12 predicted RNAs, ranked by their RPKM score
Conserved region in Mtb H37Rv
1 Region in M. Smegmatis
3
id start Orient-ation
5 length # reads RPKM Evo-fold?
2 Genes flanking the intergenic region Start Stop # reads RPKM
RNA1
4 1612987 –+ 58 1013 69526 Y Rv1435c (secreted protein) Rv1436 (GAPDH) 756567 756626 100 626
RNA2
4 1374224 — 46 567 30071 Y Rv1230c (membrane prot.) Rv1231c (membrane prot.) - - -
RNA3
4 1393055 — 85 111 9251 Y Rv1248c (sucA) Rv1249c (membrane prot.) 5147110 5147242 173 489
RNA4 483829 -++ 49 55 2139 Y Rv0403c (membrane prot. mmpS1) Rv0404 (fadD30) - - -
RNA5 1200514 -++ 93 81 2055 Y Rv1075c (exported protein) Rv1076 (lipase lipU) 5363400 5363474 10 50
RNA6 987053 -++ 92 174 6767 Y Rv0887c (cons. Hypo. prot) Rv0888 (hyp. Exported prot.) - - -
RNA7 1810184 +++ 44 517 9280 Y Rv1610 (cons. membrane protein) Rv1611 (trpC) 3296996 3297034 291 2804
RNA8 3587635 -++ 56 83 6917 N Rv3210c (cons. hypo. prot.) Rv3211 (rhlE) 2009575 2009665 6 25
RNA9
4 4224925 –+ 41 502 24405 N Rv3778c (aminotransf.) Rv3779 (membrane prot.) 6420618 6420674 36 237
RNA10 659351 +++ 39 58 1829 Y Rv0567 (methyltransferase) Rv0568 (cyp135B1) - - -
RNA11 1794708 -++ 48 375 18231 Y Rv1593c (cons. hypo. prot) Rv1594 (nadA) 3277552 3277599 70 548
RNA12 2447526 — 74 332 9684 Y Rv2185c (cons. hypo. prot) Rv2186c (cons. hypo. prot) 4335086 4335137 111 802
1Conserved intergenic regions determined by Gumby.
2Indicates whether this region is predicted to fold by Evofold.
3Region in M. smegmatis that aligns with the conserved region in Mtb, and its corresponding RPKM value.
4Tested experimentally
5Orientation relative to neighboring genes. The first and last characters give the strands of the flanking genes; the middle character gives the strand for the predicted RNA.
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7Table 7 Motifs passing our set of stringent filters, ranked by their degree of conservation
k
a Cluster # Motif MAP score
b Specificity
c Known
d Palind-romicity
e Conser-vation
f Motif Logo
g
100 71 1 65.6 1.8E-29 KstR 0.93 46
250 179 1 88.6 4.8E-26 KstR 0.71 43
50 35 1 87.4 1.8E-19 KstR 0.79 40
200 182 1 94.2 5.7E-28 KstR 0.80 36
100 73 2 31.3 1.5E-32 IdeR 0.85 30
100 49 15 16.3 2.8E-18 KstR 0.71 29
250 112 1 25.5 2.1E-25 DosR 0.76 21
100 80 1 15.0 2.2E-14 0.92 21
50 29 1 15.0 2.2E-14 0.92 21 X
50 23 31 21.7 6.7E-24 0.71 18
200 47 64 7.2 1.2E-15 0.75 16
250 87 1 22.1 1.5E-13 ZurB 0.94 16
200 6 1 16.3 2.0E-12 IdeR 0.70 16
200 184 19 12.1 4.7E-13 0.75 16
250 123 18 14.5 3.7E-11 0.82 16
250 224 1 26.9 6.2E-24 DosR 0.73 15
200 46 3 19.8 1.6E-12 0.78 15
100 5 25 12.4 3.8E-15 0.71 14
200 120 62 15.3 2.0E-14 0.74 14
200 71 9 16.6 2.3E-16 0.75 14
200 195 1 25.4 7.2E-26 DosR 0.76 14
50 48 1 68.8 6.4E-35 DosR 0.86 13
100 74 1 66.9 3.6E-34 DosR 0.88 13
50 23 12 26.8 5.0E-22 0.73 13
250 89 1 46.636 4.0E-20 0.75 12
100 81 84 6.4 2.3E-16 0.71 12
250 92 6 5.7 3.7E-17 DosR 0.73 12
100 52 91 9.7 1.5E-18 0.76 11
200 91 1 47.1 4.7E-20 0.70 10
50 36 43 34.8 4.6E-30 0.72 10
100 42 4 15.3 2.8E-17 0.70 10
200 80 9 8.5 4.0E-13 0.72 10
50 43 7 15.7 8.7E-12 0.72 10
50 36 21 48.5 5.3E-12 0.71 10
200 26 17 7.5 2.1E-12 0.70 9
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transcription factor binding site motifs.
The most striking features of our analysis are related
to lipid metabolism and its regulation. In addition to
observing a general expansion of lipid metabolism genes
in the Mycobacteria and Rhodococcus, we observe
increased expansions of genes related to saturated fatty
acid metabolism in the pathogenic Mycobacteria com-
pared to the soil-dwelling Mycobacteria. We also note
differences in evolutionary profiles for catabolic and
anabolic lipid metabolism genes, and evidence for posi-
tive selection in lipid metabolism genes. The cis-regula-
tory elements bound by the KstR protein, a known
regulator of lipid/cholesterol metabolism, are among the
strongest, most highly conserved noncoding signals
across the Mycobacteria. Both KstR and its binding sites
are highly conserved, appearing at the last common
ancestor between Rhodococcus and the Mycobacteria.
Within our set of organisms, we examine the evolu-
tion of pathogenicity, moving from the soil-dwelling
Mycobacteria up to the intracellular parasites of the
Mtb complex. We see expansions of many known gene
families related to pathogenicity (PE/PPE genes, antibio-
tic resistance genes, genes involved in the synthesis of
the mycolic acid coat, MCE genes, and Esx genes). By
similarity of phylogenetic profiles, we can predict likely
candidates for novel gene families related to pathogeni-
city. For example, we see similar expansions in gene
families related to biosynthesis of molybdopterin. We
further observe evidence of positive selection on molyb-
denum-related genes, providing further support for the
importance of molybdenum in these pathogens. On the
branch leading to the pathogenic Mycobacteria, we also
observe evidence for positive selection in genes related
to replication, recombination, and repair. It is possible
that these DNA repair-related processes give the patho-
genic Mycobacteria an advantage when dealing with the
assault on its DNA by macrophage-generated reactive
oxygen and nitrogen intermediates.
Our whole-genome alignments, coupled with RNA-seq
and microarray data, allowed us to predict novel non-
coding features, including small RNAs (four of which
we have validated experimentally), and potential tran-
scription factor binding sites.
The main forces driving genome evolution in prokaryotes
include gene genesis, lateral gene transfer, and gene loss.
Our analysis of protein evolution using SYNERGY does not
examine whether orthogroups appearing have arisen by lat-
eral gene transfer or by gene genesis involving duplication
and divergence from other orthogroups. A detailed com-
parison to categorize these orthogroup appearances accord-
ing to lateral or vertical gene transfer is beyond the scope of
this study, but other studies indicate that lateral gene trans-
fer has played a significant role in Mycobacterial evolution
and the evolution of pathogenesis [79-83].
A recent paper suggests that the Mycobacterial gen-
ome has been shaped by a biphasic process involving
gene acquisition (including lateral gene transfer) and
duplications followed by gene loss [79]. Other studies
report numerous genes, including a large number
involved in lipid metabolism, that have been acquired by
horizontal gene transfer at different phylogenetic strata
and have led to the emergence of pathogenesis in Mtb
[80,81]. Previous studies indicate a possible more
ancient lateral gene transfer of fatty acid biosynthesis
genes from a-proteobacteria to actinobacteria [84].
However, genetic studies show that the Mtb complex
and pathogenic Mycobacteria do not exchange genetic
material frequently [85,86], so there is limited lateral
gene transfer within the Mtb complex.
We are currently performing high-throughput Chroma-
tin Immunoprecipitation (ChIP)-Seq experiments in sev-
eral different Mycobacteria, including Mtb, M. smegmatis,
and M. vanbaalenii[87]. We plan to integrate the informa-
tion obtained from our comparative analysis with data
coming from these high-throughput experiments, as well
as other ‘omic datasets, using a systems biology approach.
This will enable construction of gene regulatory networks
for Mtb, and examination of their evolution across species.
Methods
Genome sequences
The 31 organisms used in our analysis are described in
Table 1. These genome sequences are all contained in
Table 7 Motifs passing our set of stringent filters, ranked by their degree of conservation (Continued)
50 6 61 6.3 1.2E-11 0.73 9
50 11 43 13.7 1.4E-11 0.72 14
ak indicates the value of k in the k-means clustering process (50, 100, 200, or 250)
bMAP score indicates the AlignACE MAP score [76]
cSpecificity score [77]
dCompareACE score ≥ 0.7 to the alignment for this known motif
eCompareACE score to its reverse complement
fnumber of ScanACE hits in the genome that are conserved in ≥ 8 genomes
gsequence logo [78]
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sequences generated at the Broad Institute (M. tubercu-
losis F11, M. tuberculosis Haarlem,a n dM. tuberculosis
C) are high-quality genome sequences. M. tuberculosis
F11 and M. tuberculosis Haarlem are finished, and M.
tuberculosis C has 6.7× coverage and 4 scaffolds. The
Broad Institute sequencing read pipeline interacts with
the sample management system to ensure the read is
associated with the correct sample. Vector identification,
length checks and quality clipping were performed on
all reads. Contamination checks and organism checks
were also performed using a kmer-based algorithm that
can compare sequence to a profile from any organism.
Defining protein families and constructing phylogenetic
trees
The SYNERGY algorithm [27,28] was applied to the 31
genomes in Table 1. SYNERGY organizes groups of
genes across organisms into orthogroups, or groups of
orthologs and paralogs, which consist of all the genes
descended from a single ancestral gene in the species’
last common ancestor. SYNERGY also associates
orthogroups with a gene tree, from which we can derive
an “extended phylogenetic profile”,s h o w i n gt h eg e n e
copy number in each extant organism and at each
ancestral node. Importantly, by reconciling an organism
tree with each gene tree, SYNERGY provides an evolu-
tionary scenario for each gene tree predicting where all
losses, gains, and duplications occurred in its evolution.
These lists of losses, gains, and duplications contain
actual evolutionary events, as well as artifacts caused by
genes that could not be properly categorized by
SYNERGY. However, we observe that SYNERGY is
effective at properly categorizing genes into orthogroups,
and the SYNERGY orthogroups were very useful in our
analysis. Analysis of the 31 genomes resulted in a total
of 32,505 orthogroups, including those containing single
g e n e sf r o mo n l yas i n g l eg e n o m e( b e l o w ) .T h e r ew e r e
177 “uniform” (1:1:1:1...) orthogroups representative of
some of the most conserved and indispensible house-
keeping genes. Additional file 4: Figure S3 summarizes
the SYNERGY orthogroups.
We started running SYNERGY using an initial phylo-
genetic tree generated using orthologs based on bidirec-
tional best BLAST hits. The list of uniform orthogroups
from the first SYNERGY run was used to construct a
refined phylogenetic tree. SYNERGY was then re-run
using the refined phylogenetic trees. To generate our
final phylogenetic tree, the final set of 177 31-way
orthologs (31-way uniform orthogroups from the
SYNERGY analysis) were aligned according to their
nucleotide sequences with CLUSTALW [88] and conca-
tenated, distances were computed with Phylip’s
DNADIST algorithm [89], and Phylip’sF I T C Ha l g o -
rithm was used to create the tree.
Because of the similarity of the genomes within the
Mtb complex, we were not able to resolve the phylogeny
using only these 177 proteins that are uniform across all
31 organisms. In order to better resolve the tree within
the Mtb cluster, we computed a separate tree using
1747 orthogroups that are uniform across the Mtb clus-
ter and M. ulcerans, which we used as an outgroup.
Using this expanded gene set, we were able to resolve
the tree for the Mtb cluster.
Bootstrap analysis was performed to validate tree
topologies. Phylip’sS E Q B O O Tw a su s e dt oc r e a t e1 0 0 0
bootstrap input replicates for each tree. Phylip’sC O N -
SENSE was used to obtain a bootstrap tree (Additional
file 5: Figure S4)
Metabolic pathways and functional groups
EFICAZ [90] was used to assign EC numbers for pro-
teins in all 31 organisms. Metabolic pathways were con-
structed in Biocyc [91,92]. An orthogroup was
considered to be part of a metabolic pathway if any of
its component genes had been identified as part of that
pathway using this pipeline.
We obtained the Gene Ontology (GO) [29] and GO
Slim terms for each of the 31 organisms using BLAS-
T2GO [93]. PFAM assignments [30] were taken from
http://www.tbdb.org[75]. An orthogroup was associated
with a GO, GO Slim, or PFAM descriptor if greater
than half of its protein members were associated with
that descriptor.
For each node in the phylogenetic tree, we tabulated
orthogroups lost, gained, or duplicated. Using GO
terms, GO Slim terms, and PFAM domain groupings
with less than 500 members, we calculated over-repre-
sentations within losses, gains, and duplications each of
these groupings at each node using the hypergeometric
test. A complete summary of gains, losses, and duplica-
tions for all nodes in the phylogenetic tree is available
on our supplementary information website.
Phylogenetic profiles
Extended phylogenetic profiles for each category (meta-
bolic pathways, GO terms, GO Slim terms and PFAM
categories) were obtained from SYNERGY output by
summing the phylogenetic profiles from their compo-
nent orthogroups. We define a category-level phyloge-
netic profile as the sum of its component orthogroup-
level phylogenetic profiles. The evolution of each of
these categories can be quickly visualized on our web-
site. Since genes with the same phylogenetic profile can
be linked functionally [94], the webpage for each cate-
gory contains a link to other categories with similar
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most similar profiles were obtained by calculating Eucli-
dean distances to all other profiles.
Instances of expanded or missing pathways across the
31 organisms will have non-uniform pathway-level phy-
logenetic profiles. Thus we tabulated the number of
genes in each genome for each category, and automati-
cally searched for gene categories whose copy number
(normalized for genome size) had the most non-uniform
distribution across the 31 organisms in order to identify
the most significant examples of expansions or losses.
To identify categories with bimodal properties (such as
a categories with a loss or a large expansion on only
certain branches of the phylogenetic tree), we clustered
each profile into two groups and looked for the path-
ways with the greatest separation between the two clus-
ters. We used k-means (k = 2) to cluster the profile
vectors, and compared the intra- and inter-cluster
point-to-centroid distances to find the clusters with the
greatest separation. We ranked categories by this separa-
tion to find bimodal categories. We further select those
that have at least five organisms in the smallest of the
two clusters, and an average of at least five genes per
genome. P-values are calculated from a T-test between
the values for the two groups, with Bonferroni correc-
tion applied. In our Supplementary Information website
we list those categories with p < 0.05, ranked by the dif-
ference between their inter- to intra-centroid distances.
When we select the metabolic pathways, PFAM
domains, and GO terms with the most non-uniform
category-level phylogenetic profiles overall, we find that
many of the top categories are lipid metabolism-related
categories expanded in the Mycobacteria.
We also measured the similarity between evolutionary
profiles to find the PFAM categories and GO terms
with the biggest difference between pre-defined sets of
organisms. For example, we compared both the Mtb
complex and a group consisting of other pathogenic
Mycobacteria to the set of soil-dwelling Mycobacteria in
order to examine the evolution of soil-dwelling, free-liv-
ing Mycobacteria into more pathogenic Mycobacteria
that require a host to survive. We used the following
categories:
1. All Mycobacteria (excluding M. leprae because of
its massive gene loss).
2. All non-Mycobacteria in our set (excluding Nocar-
dia and Rhodococcus because of their similarity to
Mycobacteria)
3. Mtb complex (8 organisms)
4. Other pathogenic Mycobacteria (M. ulcerans, M.
avium 104, M. avium K10, M. marinum).
5. Soil-dwelling Mycobacteria that do not require a
host (M .s p .M C S ,Ms p .K M S ,M .s m e g m a t i s ,M .v a n -
baalenii, M. abscessus, M. gilvum).
6. R. jostii RHA1 and N. farcinia
We calculated differences between two sets of organ-
isms exactly as we calculated distances between clus-
ters (above). However, rather than using different
clusters of organisms determined by k-means cluster-
ing, we used these pre-defined clusters of organisms.
We looked at distances between the following sets of
organisms: 1-2, 3-4, 3-5, 3-6, 4-5, 4-6, 5-6. For each
PFAM domain or GO term represented in at least two
organisms in these pairings, we calculated p-values for
the differences between the profile values by T-test
(Bonferroni-corrected by the number of PFAM
domains represented in that set of organisms) and
computed inter-and intra-centroid distances (as
described in the above paragraph). We compiled lists
of those that are most expanded and a list of those
most contracted across these pairings. On our website
we have included complete lists of PFAM categories,
including those that do not make the strict Bonfer-
roni-corrected p-value cutoff. Many potentially inter-
esting expansions do not make the overly conservative
Bonferroni-corrected p-value cutoff [95,96].
Motif discovery
Using a compendium of 946 microarray experiments
from the TB database [75], we used several different
clustering methods to generate predicted regulons. We
searched the upstream regions of these regulons for
shared transcriptional regulatory motifs. We clustered
microarray data by hierarchical and k-means clustering.
Because real regulons can be of varying sizes, we per-
formed k-means with k = 50, 100, 200, and 250, then
used all the resulting clusters for further analysis. We
found that the clusters obtained from hierarchical clus-
tering were not very useful because their size distribu-
tion did not approximate that of real regulons as well as
those from k-means; therefore we did not analyze clus-
ters from hierarchical clustering further.
We used AlignACE [97] to search the upstream
regions of the genes in these clusters for motifs. We
used the methods for operon prediction, selecting
upstream regions, and applying AlignACE to prokaryotic
genomes as described in McGuire et al. [77]. Briefly,
because of the presence of operons in prokaryotes, we
must choose the upstream region of the operon head
rather than the region immediately upstream of the
gene of interest. Since it is more important to include
the correct region than to erroneously include extra
incorrect regions, we use a loose operon definition and
include sequences for several different possibilities if
there is any ambiguity. We look upstream of our gene
of interest and select all intergenic sequences until we
encounter either a divergent intergenic region or an
intergenic region longer than 300 bp.
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ters: specificity score [77], quality of alignment (AlignACE
MAP score) [97], palindromicity [77], and conservation.
To determine the degree of conservation, a search matrix
was constructed for each motif. Each of the other genomes
was searched with this search matrix using CompareACE,
and N-way conserved sites were identified. N-way con-
served hits are hits identified upstream of orthologous
genes in N genomes, where orthology is defined by mem-
bership in the same SYNERGY orthogroup. To select
interesting motifs we required specificity score < 1e-10,
palindromicity > 0.7, MAP score > 5, and at least 8 sites
conserved in 8 genomes.
Motifs were compared to a library of search matrices
for 9 known Mtb m o t i f s( A c r ,C r p ,C s o R ,D o s R ,F u r A ,
IdeR, KstR, MprAB, and ZurB), as well as a library of 55
E. coli motifs [98] and 22 Corynebacterial motifs [99].
Comparison of motifs was done using CompareACE [76].
Defining groups based on expression under different
lipids
We separated the experiments in our compendium of
Mtb H37Rv microarray experiments into separate condi-
tions based on what nutrients were present in their
growth conditions (focusing on different lipid condi-
tions, because of the observed importance of lipid meta-
bolism in these organisms). The following categories
were used (the number of experiments in each category
is shown in parentheses): Palmitic acid (168), Oleic acid
(102), Arachidonic and Eicosatetraynoic acids (76), Lino-
leic acid (41), Eicosatetraynoic acid (13), Ceramide (4),
Nordihydroguaiaretic (3), Cholesterol (2), Glucose (1),
KstR knockout (1), KstR knockout with cholesterol
added (1).
Within each experiment, we extracted a list of genes
upregulated 1.5 and 2 standard deviations above the
mean. For each category, we considered a gene to be
upregulated if it was upregulated in more than 50% of
the experiments making up that category. We then
searched for genes that were only upregulated under
certain conditions or sets of conditions.
We looked at the evolution of these sets of Mtb
H37Rv genes by taking the other members of their
orthogroups across all 31 other organisms. Evolution of
these groups can be visualized in our supplementary
information http://www.broadinstitute.org/ftp/pub/seq/
msc/pub/SYNERGY/index.html.
dN/dS Analysis
We used PAML to calculate dN/dS values according to
several different evolutionary models [100,101]. Since
orthogroups contain paralogs as well as orthologs, we
used the gene trees output from SYNERGY when run-
ning PAML. Some orthogroups may contain single-copy
orthologs in only two closely related organisms, whereas
others could contain paralogs in all 31 organisms.
For the basic model, we used the following para-
meters: model = 0 and getSE = 1 (to calculate standard
errors). This simple evolutionary model gives one value
of dN/dS for each orthogroup, averaged over all lineages
as well as all positions in the gene [102]. While this
model does not reflect the evolutionary history that has
taken place, it is nevertheless a very blunt yet efficient
tool for observing selection.
To gain insight into the evolution of the three major
c l a d e so ft h ep h y l o g e n e t i ct r e ew ea l s ou s e da“branch
model” where a different dN/dS value is allowed on a
“foreground” branch (but dN/dS is averaged along posi-
tions in the protein) [103,104]. This was done in PAML
by using “Model = 2”. We compared this model to the
basic model using a log-likelihood c
2 test with d.o.f. = 1.
For each of the three foreground branches, we used a
Bonferroni correction equal to the number of
orthogroups present at the branch. We ran this sepa-
rately for three different “foreground” branches on the
phylogenetic tree (labeled in Figure 1): A) The branch
leading to the Mtb complex; B) The branch leading to
pathogenic Mycobacteria; and C) The branch leading to
soil-dwelling, non-pathogenic Mycobacteria. The log-
likelihood model that we use here compares this branch
model to the simple model with a single value of dN/dS
described above, and tests whether the model allowing
dN/dS to differ on the foreground branch fits the data
better than the basic model.
Branch-site models allow dN/dS to vary across
branches of the tree and among sites in the protein. We
also used the branch-site model of Zhang and Nielsen
[100] using Model = 2, NSsites = 2, and fix_blength = 2.
We used the model = 0 calculations to determine
branch lengths for the branch-site model calculations to
save computational time. We compared the results for a
subset of the orthogroups with and without fixed tree
lengths and determined there was little difference in the
results). We chose the same three sets of branches (A-
C) that we used for the branch model described above.
We compared this model to the corresponding null
model using a log-likelihood c
2 test with d.o.f. = 1
[100]. For each of the three foreground branches, we
used a Bonferroni correction equal to the number of
orthogroups present at the branch. The branch-site
model was the most informative.
We calculated the functional group over-representa-
tions separately for each functional group dataset. These
datasets included 21 COG categories, 168 KEGG cate-
gories, 749 metabolic pathways, and 7 additional Myco-
bacteria-specific groupings (PE genes, PPE genes, toxin-
antitoxin genes, DosRr e g u l o n ,e s xg e n e s ,Rv0474 regu-
lon, and the KstR regulon). We multiplied the
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equal to the number of categories or tests performed.
Generating multi-genome alignments
We constructed whole-genome alignments of all 31
organisms, as well as subsets including only Mycobacter-
ial organisms, and organisms within the Mtb complex.
These alignments can be downloaded from our website.
Our whole genome multiple alignments reveal unanno-
tated stretches of conservation in noncoding regions
including transcription factor binding sites in promoter
regions, noncoding RNAs, and mis-annotated proteins.
To generate whole-genome multiple alignments, we
first aligned the reference genome to each target gen-
ome in a pairwise manner. The process of pairwise
whole-genome alignment consists of using Pattern-
Hunter [105] to identify anchors of local alignment,
grouping collinear anchors separated by a limited dis-
tance into chains, filtering out smaller chains that sha-
dow larger ones, and finally using LAGAN [106] to
globally align the entire chain. Once all genomes have
been aligned to the reference, we then identified
intervals of the reference that map tightly to a single
interval of some or all of the target genomes, and we
consider these the endpoints of blocks of multiple
alignment. These blocks are generally smaller than any
precursor pairwise alignment, because a rearrangement
or loss of detectable similarity in any genome will
truncate the block for all member genomes. We then
ran the multiple aligner MLAGAN on each block.
Finally, to facilitate searches for constrained regions of
the reference, we projected the blocks onto the refer-
ence genome, effectively unwinding all genome rear-
rangements in the target genomes relative to the
reference. We visualized the alignments in the Geno-
meView browser [64].
Selecting conserved regions within the alignments
We used Gumby [65] to select conserved regions in our
multiple alignments using a value of p < 0.5. In a multi-
ple alignment of all 19 Mycobacterial genomes, we iden-
tified 4697 regions of conservation overlapping coding
genes in the reference annotation, and 394 regions in
intergenic regions.
Figure 6 New predicted motif with binding sites upstream of fatty acid-related genes. a) Motif logo. b) Conserved binding site locations
for this new motif are marked with red x’s. Red lines indicate orthologous relationships between genes in Mtb H37Rv, M. avium 104, and M.
smegmatis.
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to identify conserved regions. Scores were normalized to
the background inferred from the 3 rd-base frequencies.
For all H37Rv coding sequences, all bases in the third
position were extracted from the 31-way multiple align-
ment. These were concatenated in a new multiple align-
ment only containing third bases. From this new
multiple alignment we calculated the baseline conserva-
tion which is used to normalize the conservation scores
f o rt h er e g u l a ra l i g n m e n t .B o t hs e t so fh i g h l yc o n s e r v e d
regions can be viewed as alignment tracks for the Geno-
meView browser [64], downloadable on our website.
Predicting RNAs
We predicted regions likely to form RNAs within the
conserved intergenic regions of our multiple alignment
of 19 Mycobacteria, using Evofold [66]. We divided the
intergenic region into 240-bp segments, tiled by 80 bp,
to run Evofold. Looking within intergenic regions, we
identified 536 regions with Evofold (regions greater than
5b pi nl e n g t hw i t hl e n g t h - n o rmalized folding potential
score > 0.2).
We examined these 536 regions, as well as the 394
conserved intergenic regions found by Gumby, to see if
any of these showed significant expression in our log-
phase Mtb RNA-seq data. We calculated RPKM [108]
values for each of these regions. We examined the
regions with RPKM value ≥200 and a number of RNA-
seq reads ≥ 20. We eliminated an additional 35 regions
which corresponded to known RNAs from the Mtb
annotation, or RNAs similar to those found in M. bovis
and Streptococcus [60-63], including 26 tRNAs, 2 ribos-
witches, and 3 found in other organisms.
To select intergenic regions with high levels of
expression that do not correspond to UTRs, we also
calculated RPKM values for the 100 bp regions of the
flanking genes closest to the intergenic regions. We
selected those intergenic regions with the highest ratio
of the RPKM value of the region of interest (within the
intergenic region) to the RPKM of the start/stop of the
flanking genes. We also looked for regions with a gap
in expression between the gene and the region of inter-
est. This will eliminate many regions that merely corre-
spond to UTRs, and select for regions that are
disproportionately expressed within the intergenic
region only. We found this method to be most useful
for selecting regions of interest, and successfully
enriched our top hits for previously known small
RNAs. The top 50 predicted RNAs can be viewed as a
track in the GenomeView browser (see Supplementary
Information).
We further examined log-phase RNA-seq data from
M. smegmatis to confirm that many of the orthologous
regions also show expression in M. smegmatis.
Strain, media, and culture conditions for RNA-seq
Mycobacterium tuberculosis H37Rv and M. smegmatis
w e r eg r o w na t3 7 ° ci n7 H 9m e d i as u p p l e m e n t e dw i t h
10% ADC (Becton Dickinson), 0.2% glycerol and 0.05%
Tween 80. For log phase, cells were grown to OD540 0.2.
Roller bottles were used for culturing M. tuberculosis,
and shaker flasks for M. smegmatis.
RNA isolation from in vitro cultures for RNA-seq
Bacterial pellet from log-phase cultures of M. tuberculo-
sis and M. smegmatis were resuspended in TRIzol
reagent (Invitrogen) and immediately transferred to 2
ml screw-cap tubes containing 0.1 mm zirconia/silica
beads (BioSpec Products). M. tuberculosis cells were
lysed using a FastPrep-24 bead-beater (MP Biomedicals)
3 times for 30 seconds each at speed 6. M. smegmatis
cells were lysed using MagNalyser (Roche). Samples
were kept on ice for 1 min between pulses. The TRIzol
extracted RNA was treated twice with DNAse and
further purified using RNAeasy kit (Qiagen).
Directional mRNA-seq libraries for RNA-seq
We generated mRNA-seq libraries for sequencing on
Illumina’s GA Sequencer (San Diego, CA). 2 μg purified
RNA was depleted of ribosomal RNA using Ambion’s
MICROBExpress Kit (Austin, TX) as per manufacture’s
recommended protocol. The enriched mRNA was used
to prepare libraries using Illumina’s Directional mRNA-
seq Library Prep v1.0 protocol. Briefly, 100 ng mRNA
was fragmented with cations and heat, end-repaired,
adapted by sequential ligation of unique 5-prime and 3-
prime adapters, reverse transcribed, PCR amplified, and
purified using Agencourt’s AMPure Beads (Beverly,
MA). The libraries were visualized on an Agilent 2100
Bioanalyzer (Santa Clara, CA) and found to have the
expected average fragment length of ~250 bp.
RNA isolation and Northern Blotting
Total RNA was isolated from Mtb as described pre-
viously [109] with minor modifications. Briefly, log-
phase cells were pelleted, resuspended in TRIzol (Invi-
trogen), and transferred to Lysing Matrix B tube (QBio-
gene). The cells were lysed using MagNalyser (Roche),
and RNA extracted with Trizol reagent as instructed by
the manufacturer. RNA was treated with Turbo DNase
(Ambion) for 30 minutes at 37°C twice and purified
further using TRIzol solution and 100% Ethanol.
Total RNA was separated on 10% TBE-Urea acrylamide
gels (Bio-Rad) and electroblotted onto Hybond N + mem-
branes (GE Healthcare). After UV cross-linking the mem-
branes were pre-hybridized and hybridized with labeled
probes at 48°C as per the DIG manual (Roche). Probe
sequences are CGATGGTCGAAAAGGAACTCGA-
TACGGCTATGCGGTTCT (RNA1), AGTTCACGA
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(RNA2), GACTGCCAGCAGGCGCCGCGCAATGCG
CTTGCAGGACTTC (RNA3), and GGGTGACAT
GGCTCAGGGAAGCCCGGGCGGGCTGGGACGT
(RNA9). After hybridization the membranes were washed
twice using a low stringency buffer (2× SSC, 0.1% SDS),
and a high stringency buffer (0.1× SSC, 0.1% SDS), for 15
and 5 minutes at 48°C, respectively. The membranes were
processed with DIG detection system (Roche) and exposed
to X-ray film.
Additional material
Additional file 1: Supplementary Results [110-130].
Additional file 2: Additional related tetR family regulators (2-3
copies in each environmental Mycobacterium).
Additional file 3: Northern Blots for small RNAs in M. tuberculosis.
Additional file 4: Genomes contained in orthogroups.
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